CTCBIO Inc (060590) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CTCBIO Inc (060590) has a cash flow conversion efficiency ratio of 0.079x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.64 Billion ≈ $3.82 Million USD) by net assets (₩71.75 Billion ≈ $48.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 060590 company net worth for the company's overall valuation and market capitalisation.
CTCBIO Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how CTCBIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
CTCBIO Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CTCBIO Inc ranked by their cash flow conversion efficiency. Explore CTCBIO Inc earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chia Her Industrial Co Ltd
TW:1449
|
-0.040x |
|
Brand X Co. Ltd.
KQ:337930
|
-0.020x |
|
Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares
NASDAQ:ALCY
|
1.504x |
|
Nyquest Technology Co Ltd
TWO:6494
|
0.132x |
|
FST Corp. Ordinary Shares
NASDAQ:KBSX
|
0.414x |
|
Great Computer
TWO:8047
|
-0.003x |
|
Oswal Agro Mills Limited
NSE:OSWALAGRO
|
0.081x |
|
Plastikkart Akilli Kart Iletisim Sistemleri Sanayi ve Ticaret AS
IS:PKART
|
0.157x |
Annual Cash Flow Conversion Efficiency for CTCBIO Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of CTCBIO Inc from 2013 to 2024. View current stock price of CTCBIO Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩69.62 Billion ≈ $47.18 Million |
₩4.50 Billion ≈ $3.05 Million |
0.065x | -40.69% |
| 2023-12-31 | ₩75.44 Billion ≈ $51.13 Million |
₩8.22 Billion ≈ $5.57 Million |
0.109x | -42.66% |
| 2022-12-31 | ₩95.96 Billion ≈ $65.03 Million |
₩18.22 Billion ≈ $12.35 Million |
0.190x | +150.02% |
| 2021-12-31 | ₩85.01 Billion ≈ $57.61 Million |
₩6.46 Billion ≈ $4.38 Million |
0.076x | +1036.38% |
| 2020-12-31 | ₩76.32 Billion ≈ $51.72 Million |
₩510.09 Million ≈ $345.68K |
0.007x | -70.18% |
| 2019-12-31 | ₩74.74 Billion ≈ $50.65 Million |
₩1.68 Billion ≈ $1.14 Million |
0.022x | +178.74% |
| 2018-12-31 | ₩86.87 Billion ≈ $58.87 Million |
₩-2.47 Billion ≈ $-1.68 Million |
-0.028x | -813.17% |
| 2017-12-31 | ₩73.98 Billion ≈ $50.14 Million |
₩295.30 Million ≈ $200.12K |
0.004x | -94.71% |
| 2016-12-31 | ₩90.89 Billion ≈ $61.60 Million |
₩6.86 Billion ≈ $4.65 Million |
0.076x | +420.86% |
| 2015-12-31 | ₩99.14 Billion ≈ $67.19 Million |
₩1.44 Billion ≈ $974.04K |
0.014x | +456.42% |
| 2014-12-31 | ₩85.49 Billion ≈ $57.94 Million |
₩-347.74 Million ≈ $-235.66K |
-0.004x | -113.69% |
| 2013-12-31 | ₩92.23 Billion ≈ $62.50 Million |
₩2.74 Billion ≈ $1.86 Million |
0.030x | -- |
About CTCBIO Inc
CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergi… Read more